Brain Doc dedicated 2ending #Alzheimers Disease &related dementias 4future generations; imagine a world w/o brain degeneration& #dementia! Tweets r my own views
¡Únase a @TheDrAtri- uno de los científicos más ocupados del mundo en la búsqueda de un tratamiento para el Alzheimer y la demencia- y yo en una conversación hoy a las 13, hora de Londres!
¿Tiene alguna pregunta sobre tratamientos y terapias para la #demencia?
Todavía hay tiempo para enviar preguntas e inscribirse en la primera charla de 30 minutos de mañana sobre los avances en la investigación de la enfermedad de #Alzheimer y la demencia: bit.ly/3Dr5NZ5
Together with 12 other Alzheimer’s Associations in the region, Alzheimer’s Jamaica are taking part in
@Alzdisint
newly launched #WhatsYourPlan campaign in the Caribbean.
Visit our website for more information
alzheimersjamaica.org/whatsy…
Lecanemab - to be called Leqembi has received approval from the US Food and Drug Administrattin for those living with #dementia with mild cognitive impairment or mild dementia. Good news for our community, still a lot of work to do on equity of access…
If you are prescribed hearing aids please wear them! Further evidence this month points to a correlation between correcting hearing problems and reduction in cognitive decline and eventually #dementia#hearingloss
More evidence of people with corrected hearing impairment's reduction in cognitive decline & dementia. Think our @TheLancet commision thelancet.com/article/S0140-… informed new policy of OTC hearing aids in USA. Now more people can have them. ja.ma/3Z8XREW via @JAMANeuro
This is something I have wanted to do from the first month I started at @AlzDisInt. It is so important as so many countries refuse to reimburse the few meds we have available. Those meds are now out of patent and affordable. Thanks to @LouiseProfessor@Knappem and @TheDrAtri
Today, alongside @UniofNewcastle & @CPEC_LSE, ADI submitted an application for anti-dementia medications to be included on @WHO's Essential Medicines List.
We hope this will ensure people living with #dementia everywhere have equitable & affordable access to these medications.
About 1 in 5 of us have an APOE4 gene variant, the #1 genetic risk factor for Alzheimer's disease. But the mechanism for brain injury was a mystery, now getting unraveled (cholesterol processing by oligodendrocytes) nature.com/articles/s41586-0…@naturenature.com/articles/d41586-0…
Persons with #Parkinson disease were found to be at four times the risk of #dementia compared to sex and age matched persons w/o #Parkinsons using Swedish Registry data. PD is not just disease that impacts motor functions.
#Parkinsonsdisease is not only a movement disorder. Many patients experience non-motor symptoms, and it is often overlooked that individuals living with #Parkinsons are at greatly increased risk for #dementia. By how much? See our new paper
doi.org/10.1038/s41598-022-2…
This was a stark reminder that we can reduce our own risks. This past week in the Global Regen CoLab, there have been conversations about deep thinking + meditation. Not always front of mind when humans are faced with many other priorities, but imagine the impact on hypertension.
Human beings are members of a whole,
In creation of one essence and soul.
If one member is afflicted with pain,
Other members uneasy will remain
If you have no sympathy for human pain,
The name of human you cannot retain.
Bani Adam (humankind), Sa’adi Shirazi; quoted by Dr Atri
For fluid BM aficionados: DADM recently published an editorial and two papers discussing fluid BM variability by race and in those with liver/kidney failure. There is so much we need to learn still! Please share widely. Links to the papers are in the chat below. #ENDALZ
WHO launches today an important initiative to sensitise governments to #brainhealth. #dementia and #alzheimers are part of this. It’s amazing that we still know so little about the brain and how it works, but I think this is why many governments have ignored this area for so long
Are you interested in how one can estimate more interpretable treatment effects of disease modifying therapies in #Alzheimers#clinicaltrials?
Then join my #AAIC22 talk in the session 'Novel Clinical Trial Designs and Outcome Measures' on Aug 2, 10am
#DaDaPIA@alzassociation
How can one jointly estimate a time-consistent trajectory of multiple biomarkers' evolution over the #Alzheimers continuum? And how do results compare across cohorts?
Find out in my #AAIC22 talk in the 'Modelling AD trajectories using biomarkers' session on Aug 4, 8am
#DaDaPIA